Skip to main content
Clinical Trials/IRCT20230720058857N1
IRCT20230720058857N1
Not yet recruiting
Phase 3

The effect of Moringa oral product on inflammatory factors, insulin resistance and abdominal obesity in military with metabolic syndrome, clinical trial

Artesh University of Medical Sciences0 sites102 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Artesh University of Medical Sciences
Enrollment
102

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Age between 20\-60 years old \- no specific underlying disease (such as malignancy, kidney and liver failure) \- no pregnancy or breastfeeding \- no allergy to moringa food product \- no smoking and alcohol consumption \-Completion of the consent form and interest in participating in the study \- Waist circumference above 80 cm in women and above 94 cm in men (the main criterion of IDF) \- Having the criteria of metabolic syndrome (according to the International Diabetes Federation)

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Artesh University of Medical Sciences

Similar Trials